Meis2 has a high expression profile in cholangiocarcinoma, glioblastoma, brain lower grade glioma, pancreatic adenocarcinoma, liver hepatocellular carcinoma, skin cutaneous melanoma, stomach adenocarcinoma, and thymoma. The gene discussed is MEIS2; the disease is glioblastoma.